Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents.
Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media.SomaLogic’s SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions.
It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers.The company serves biological and medical science sectors.
SomaLogic is headquartered in Boulder, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company SomaLogic Inc - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
190 pages •
By Global Industry Analysts
• Apr 2021
- Global Healthcare Nanotechnology (Nanomedicine) Market to Reach $475.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Healthcare Nanotechnology (Nanomedicine) estimated at US$183.9 Billion in the year 2020, is projected to reach a revised size of US$475.2 Billion by 2027, growing at a...
The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices. By...
Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems.The company offers products such as XT-8 systems and ePlex systems. It offers pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, and others.GenMark...
COVID-19 Impact on Shenzhen Mindray Bio-Medical Electronics Co Ltd.’s Revenue and Operations (Medical Devices)
Shenzhen Mindray Bio-Medical Electronics Co Ltd (Mindray) is a developer, manufacturer and marketer of medical devices and solutions.The company offers products for in-vitro diagnostics,...
Summary Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products.The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied markets testing for...
ADME Toxicology (Absorption, Distribution, Metabolism And Elimination)Testing Market Size, Outlook and Growth Opportunities, 2019- 2025 Global ADME Toxicology Testing Market Size, Outlook and Growth Opportunities to 2025: By Product Type (Software Solutions, Assays Systems, Reagents, and Others), By Technology Type...
Nanomedicine Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Nanomedicine Market size, Outlook and Opportunities 2019- 2025: By Modality (Treatments and Diagnostics), By Product (Therapeutics, In-vivo diagnostics, In-vitro diagnostics, Vaccines and Regenerative medicine), By Application (Clinical Oncology,...
Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics.The company’s products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays,...
Circulating tumor cells (CTCs) have tremendous utility in cancer research, aiding researchers in deciphering the complex processes leading to cancer metastasis and in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of...
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.